1. PO-1107 miR-9 as predictor of response to Radiotherapy and Cetuximab in patients with head and neck cancers. (May 2022) Authors: Fanetti, G.; Musco, L.; Citron, F.; Segatto, I.; Micciché, F.; Turturici, I.; Lupato, V.; Matrone, F.; Giacomarra, V.; Barzan, L.; Franchin, G.; Baldassarre, G. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗